$-0.65 EPS Expected for Intra-Cellular Therapies, Inc. (ITCI); Willis Lease Finance Has 1.29 Sentiment

April 23, 2018 - By Winifred Garcia

Willis Lease Finance Corp (WLFC) investors sentiment decreased to 1.29 in Q4 2017. It’s down -0.11, from 1.4 in 2017Q3. The ratio dived, as 22 funds increased and started new equity positions, while 17 sold and reduced their stakes in Willis Lease Finance Corp. The funds in our database now hold: 2.23 million shares, down from 2.26 million shares in 2017Q3. Also, the number of funds holding Willis Lease Finance Corp in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 16 Increased: 15 New Position: 7.

Analysts expect Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) to report $-0.65 EPS on May, 9.They anticipate $0.03 EPS change or 4.84% from last quarter’s $-0.62 EPS. After having $-0.56 EPS previously, Intra-Cellular Therapies, Inc.’s analysts see 16.07% EPS growth. The stock decreased 1.10% or $0.21 during the last trading session, reaching $18.89. About 116,649 shares traded. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) has risen 27.96% since April 23, 2017 and is uptrending. It has outperformed by 16.41% the S&P500.

Rutabaga Capital Management Llc Ma holds 0.29% of its portfolio in Willis Lease Finance Corporation for 50,874 shares. Menta Capital Llc owns 21,350 shares or 0.1% of their US portfolio. Moreover, Rbf Capital Llc has 0.08% invested in the company for 30,000 shares. The New York-based Maltese Capital Management Llc has invested 0.05% in the stock. Bridgeway Capital Management Inc, a Texas-based fund reported 146,550 shares.

Willis Lease Finance Corporation, together with its subsidiaries, leases commercial aircraft engines and other aircraft-related equipment to air carriers, manufacturers, and overhaul/repair facilities worldwide. The company has market cap of $220.88 million. It operates through two divisions, Equipment Leasing and Spare Parts Sales. It has a 3.55 P/E ratio. The firm also purchases and resells new and used commercial aircraft engines, as well as sells aircraft engine parts and materials.

Since January 1, 0001, it had 1 buying transaction, and 7 insider sales for $494,121 activity.

The stock decreased 0.15% or $0.05 during the last trading session, reaching $34.41. About 20,904 shares traded or 40.42% up from the average. Willis Lease Finance Corporation (WLFC) has risen 47.40% since April 23, 2017 and is uptrending. It has outperformed by 35.85% the S&P500.

Among 13 analysts covering Intra-Cellular Therapies (NASDAQ:ITCI), 12 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Intra-Cellular Therapies had 46 analyst reports since August 6, 2015 according to SRatingsIntel. Piper Jaffray maintained the stock with “Hold” rating in Wednesday, August 9 report. The stock of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) earned “Market Perform” rating by JMP Securities on Thursday, September 29. On Thursday, September 17 the stock rating was maintained by Guggenheim with “Buy”. Cowen & Co maintained the shares of ITCI in report on Thursday, March 1 with “Buy” rating. The stock of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) earned “Neutral” rating by Ladenburg Thalmann on Tuesday, May 2. The stock of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) earned “Market Perform” rating by Leerink Swann on Tuesday, May 2. The stock of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) has “Market Outperform” rating given on Wednesday, March 9 by JMP Securities. Cowen & Co maintained the shares of ITCI in report on Friday, September 8 with “Buy” rating. Piper Jaffray upgraded the shares of ITCI in report on Thursday, September 7 to “Buy” rating. The stock has “Buy” rating by Cowen & Co on Tuesday, June 6.

Since December 11, 2017, it had 0 insider buys, and 10 insider sales for $2.07 million activity. Shares for $105,630 were sold by LERNER RICHARD A. Halstead Michael sold $69,179 worth of stock. Another trade for 6,604 shares valued at $115,438 was made by Mates Sharon on Monday, January 8. Hineline Lawrence J. had sold 49,700 shares worth $995,165 on Thursday, February 15. Davis Robert E sold 1,115 shares worth $17,394. 772 shares valued at $13,479 were sold by Vanover Kimberly E. on Monday, January 8.

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: